Investing Profile

David Goeddel

InvestorVC

Managing Partner at The Column Group

thecolumngroup.com/member/dav...Burlingame, California
Photo of David Goeddel, Managing Partner at The Column Group

Signal uses Gmail to reveal intro paths. Email content is never read.

Sign in with Google →
cb
The Column Group Managing Partner
$100K - $5.0M
$1.5M
14
$600M
CompanyStageDateRound SizeTotal Raised
Hexagon Bio
Series BSep 2021$61M
Series ASep 2020$47M
$110M
Co-investors: Millie Ray (The Column Group), Jakob Loven (Nextech Invest), Dusan Perovic (Two Sigma Ventures), Alex Kolicich (8VC)
Exonics Therapeutics
Series ANov 2017$40M
$40M
Peloton Therapeutics
Series DSep 2016$52M
$200M
Co-investors: Jim Tananbaum (Foresite Capital)
NGM Biopharmaceuticals
Series DMar 2015$58M
Series BNov 2011$55M
Series ADec 2009$27M
$140M
Co-investors: Peter Svennilson (The Column Group)
Flexus Biosciences
Series BDec 2014$38M
$66M
Co-investors: Beth Seidenberg (Kleiner Perkins)
Nurix Therapeutics
Series BMay 2014$25M
Seed RoundMay 2012$3.1M
$150M
Co-investors: Michael Rome (Foresite Capital)
Igenica
Series CJan 2014$14M
Series CJun 2012$33M
Series BJun 2010$24M
$71M
Co-investors: Carl Gordon (OrbiMed), Richard Ulevitch (5am Ventures)
Constellation Pharmaceuticals
Series CJan 2012$95M
$150M
Co-investors: Robert Tepper (Third Rock Ventures), Tony Evnin (Venrock), Brian Gallagher (Abingworth)